Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2019 / N 3

Лекарственно-индуцированная апластическая анемия
О.Д. Остроумова, Ю.И. Сапожникова, А.И. Кочетков

Список литературы

1. Национальное гематологическое общество. Клинические рекомендации по лечению апластической анемии. Под ред. Савченко В.Г. М., 2014.
2. Norris LB, Bennett CL. Anemias. In: Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. 3rd ed. Bethesda, MD: American Society of Health-System Pharmacists; 2018: 1099-114.
3. Al Qahtani SA. Drug-induced megaloblastic, aplastic, and hemolytic anemias: current concepts of pathophysiology and treatment. International Journal of Clinical and Experimental Medicine 2018;11(6):5501-12.
4. Böttiger LE, Furhoff AK, Holmberg L. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Medica Scandinavica 1979;205:457-61.
5. Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, McCann SR, Mercieca J, Oscier D, Roques AW, Yin JA; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquitted aplastic anaemia. British Journal of Haematology 2003 Dec;123(5):782-801.
6. Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R. Systematic review: hepatitis-associated aplastic anaemia – a syndrome associated with abnormal immunological function. Alimentary Pharmacology & Therapeutics 2009 Sep;30(5):136-43.
7. Issaragrisil S, Kaufman DW, Anderson T, Chan-sung K, Leaverton PE, Shapiro S, Young NS. The epidemiology of aplastic anemia in Thailand. Blood 2006 Feb;107(4):1299-307.
8. Montané E, Ibáñez L, Vidal X, Ballarín E, Puig R, García N, Laporte JR; Catalan Group for Study of Agranulocytosis and Aplastic Anemia. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 2008;93:518-23.
9. Miano M, Dufour C. The diagnosis and treatment of aplastic anemia: a review. International Journal of Hematology 2015 Jun;101(6):527-35.
10. Nimer SD, Ireland P, Meshkinpour A, Frane M. An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood 1994 Aug;84(3):923-7.
11. Poonkuzhali B, Shaji RV, Salamun DE, George B, Srivastava A, Chandy M. Cytochrome P4501A1 and glutathione S transferase gene polymorphisms in patients with aplastic anemia in India. Acta Haematologica 2005;114(3):127-32.
12. Young NS, Maciejewskj J. The pathophysiology of acquired aplastic anemia. The New England Journal of Medicine 1997 May;336(19):1365-72.
13. Vandendries ER, Drews RE. Drug-associated disease: hematologic dysfunction. Critical Care Clinics 2006 Apr;22(2):347-55, viii.
14. Rao KV. Drug-induced hematologic disorders. In: Pharmacotherapy: a pathophysiologic approach. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. 9th ed. New York, NY: McGraw-Hill; 2014.
15. Yunis AA, Miller AM, Salem Z, Arimura GK. Chloramphenicol toxicity: pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia. Clinical Toxicology 1980 Oct;17(3):359-73.
16. Hielmpel H. Epidemiology and etiology of aplastic anemia. In: Aplastic anemia: pathophysiology and treatment. Schrevenmeier H, Bacigalupo A, editors. Cambridge, UK: Cambridge University Press; 1999: 97-116.
17. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979 Mar;53(3):504-14.
18. Shadduck R. Aplastic anemia. In: Williams Hematology. Kaushansky K, Lichtman MA, Beutler E, editors. 5th ed. New York: McGraw-Hill;1995: 375-90.
19. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. The New England Journal of Medicine 1997 May;336(19):1365-72.

References

1. Russian National Hematology Society. Clinical recommendations for treatment of aplastic anemia. Savchenko VG, editor. Moscow, 2014. (In Russian).
2. Norris LB, Bennett CL. Anemias. In: Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. 3rd ed. Bethesda, MD: American Society of Health-System Pharmacists; 2018: 1099-114.
3. Al Qahtani SA. Drug-induced megaloblastic, aplastic, and hemolytic anemias: current concepts of pathophysiology and treatment. International Journal of Clinical and Experimental Medicine 2018;11(6):5501-12.
4. Böttiger LE, Furhoff AK, Holmberg L. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Medica Scandinavica 1979;205:457-61.
5. Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, McCann SR, Mercieca J, Oscier D, Roques AW, Yin JA; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquitted aplastic anaemia. British Journal of Haematology 2003 Dec;123(5):782-801.
6. Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R. Systematic review: hepatitis-associated aplastic anaemia – a syndrome associated with abnormal immunological function. Alimentary Pharmacology & Therapeutics 2009 Sep;30(5):136-43.
7. Issaragrisil S, Kaufman DW, Anderson T, Chan-sung K, Leaverton PE, Shapiro S, Young NS. The epidemiology of aplastic anemia in Thailand. Blood 2006 Feb;107(4):1299-307.
8. Montané E, Ibáñez L, Vidal X, Ballarín E, Puig R, García N, Laporte JR; Catalan Group for Study of Agranulocytosis and Aplastic Anemia. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 2008;93:518-23.
9. Miano M, Dufour C. The diagnosis and treatment of aplastic anemia: a review. International Journal of Hematology 2015 Jun;101(6):527-35.
10. Nimer SD, Ireland P, Meshkinpour A, Frane M. An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood 1994 Aug;84(3):923-7.
11. Poonkuzhali B, Shaji RV, Salamun DE, George B, Srivastava A, Chandy M. Cytochrome P4501A1 and glutathione S transferase gene polymorphisms in patients with aplastic anemia in India. Acta Haematologica 2005;114(3):127-32.
12. Young NS, Maciejewskj J. The pathophysiology of acquired aplastic anemia. The New England Journal of Medicine 1997 May;336(19):1365-72.
13. Vandendries ER, Drews RE. Drug-associated disease: hematologic dysfunction. Critical Care Clinics 2006 Apr;22(2):347-55, viii.
14. Rao KV. Drug-induced hematologic disorders. In: Pharmacotherapy: a pathophysiologic approach. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. 9th ed. New York, NY: McGraw-Hill; 2014.
15. Yunis AA, Miller AM, Salem Z, Arimura GK. Chloramphenicol toxicity: pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia. Clinical Toxicology 1980 Oct;17(3):359-73.
16. Hielmpel H. Epidemiology and etiology of aplastic anemia. In: Aplastic anemia: pathophysiology and treatment. Schrevenmeier H, Bacigalupo A, editors. Cambridge, UK: Cambridge University Press; 1999: 97-116.
17. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979 Mar;53(3):504-14.
18. Shadduck R. Aplastic anemia. In: Williams Hematology. Kaushansky K, Lichtman MA, Beutler E, editors. 5th ed. New York: McGraw-Hill;1995: 375-90.
19. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. The New England Journal of Medicine 1997 May;336(19):1365-72.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]